Back to top

Analyst Blog

This page is temporarily not available.  Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext.  9339.

St. Jude Medical (STJ - Analyst Report) has received CE Mark approval for two of its devices viz. the AMPLATZER Amulet Left Atrial Appendage Occluder and the ViewFlex Xtra Intracardiac Echocardiography (ICE) Catheter. Both the products were unveiled at the 18th annual Boston AF Symposium.  

About AMPLATZER Amulet

The advanced Amulet cardiovascular device from the company’s Cardiovascular and Ablation Technologies Division (CATD) is technically a notch above the original AMPLATZER Cardiac Plug, as it can be used to treat a wider range of appendage anatomies. The percutaneous transcatheter device is intended to seal off left atrial appendage (LAA) in patients ailing from non-valvular atrial fibrillation (AF).

As per the World Health Organization (WHO), strokes occur in approximately 15 million people across the globe every year, rendering it to be one of the leading causes of death and long-term disability. Following the success of the AMPLATZER Cardiac Plug, the Amulet device should further boost structural heart devices sales. However, it has not yet been cleared by the U.S. Food and Drug Administration (FDA). Edwards Lifesciences Corp. (EW - Analyst Report) also manufactures transcatheter heart valves and currently carries a Zacks Rank #2 (Buy).  

About ViewFlex Xtra

St. Jude’s ViewFlex Xtra ICE Catheter, again from the Cardiovascular and Ablation Technologies Division (earlier AF division), also received the European CE Mark and is already FDA approved. The catheter allows seamless movement during cardiac ablation surgeries, thereby enhancing clinical outcomes.

Along with the ViewMate Z Intracardiac Ultrasound Console, the device provides real-time image guidance and visualization of a patient’s cardiac anatomy and is capable of delivering fast, high-fidelity images, which helps physicians during electrophysiology procedures.

St. Jude forayed into the high-growth ICE market in 2008 with the acquisition of leading electrophysiology products maker EP MedSystems. The medical devices behemoth obtained the ViewFlex ICE catheters and ViewMate II ultrasound imaging system through this acquisition. Medtronics Inc. (MDT - Analyst Report) is also expanding its foothold in the emerging AF market.

St. Jude will be reporting its fourth-quarter earnings results on Jan 23 and currently carries a Zacks Rank #3. We also look forward to orthopedic major, Stryker Corp.’s (SYK - Analyst Report) results, releasing tomorrow.   
 

Please login to Zacks.com or register to post a comment.

New to Zacks?

Start Here

Zacks Investment Research

Close

Are you a new Zacks Member or a visitor to Zacks.com?

Top Zacks Features

Learn more

Start for as little as $4.50 per trade.

My Portfolio Tracker

Is it Time to Sell?

One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts.

More Zacks Resources

Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.

Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.

Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.

My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.

Zacks #1 Rank Top Movers for Zacks #1 Rank Top Movers

Company Symbol Price %Chg
BITAUTO HOLD BITA 35.33 +14.82%
ANI PHARMACE ANIP 24.79 +14.66%
E HOUSECHINA EJ 10.99 +9.24%
CANADIAN SOL CSIQ 26.97 +7.15%
INTERNATIONA ICAGY 33.30 +5.38%